期刊文献+

高脂血症对直肠癌不同手术方式合并症的影响 被引量:1

Effects of Hyperlipidemia on Postoperative Complications in Patients of Rectal Cancer with Different Surgical
原文传递
导出
摘要 目的:探讨高脂血症对直肠癌不同手术方式合并症的影响。方法:回顾分析行开腹或腹腔镜直肠癌根治术治疗的255例患者的临床资料,比较伴或不伴高脂血症患者的围手术期指标,采用卡方检验或t检验进行统计学分析。结果:与非高脂血症组患者相比,高脂血症组术中出血量大(P<0.01),术后恢复进食时间长(P<0.01),术后住院时间增加(P<0.05),拔除引流管时间延长(P<0.01),切口脂肪液化并发症增多(P<0.05)。与开腹组相比,腹腔镜组术中出血量少(P<0.01),手术时间、术后恢复进食时间、术后住院时间、拔除引流管时间均明显缩短(均为P<0.01),切口脂肪液化发生率低(P<0.05)。在腹腔镜手术组,与正常血脂组相比,高脂血症患者术中出血量较大(P<0.01),余指标无明显差异。结论:高脂血症可引起直肠癌手术出血量增加、术后恢复慢、伤口脂肪液化发生率高,腹腔镜手术可加快患者术后恢复。 Objective: To investigate the effects of hyperlipidemia on postoperative complications in patients of rectal cancer with different surgical.Methods: A retrospective analysis on clinical data of 255 patients underwent open or laparoscopic rectal cancer surgical were reviewed.Perioperative indicators of patients with or without hyperlipidemia were compared.Chi-square test or t test was used for statistical analysis.Results: Compared to non-hyperlipidemic patients,hyperlipidemia group had more blood loss volume(P〈0.01),more postoperative recovery time for eating(P〈0.01),increased postoperative hospital stay(P〈0.05),prolonged removal of drainage tube(P〈0.01),increased fat liquefaction(P0.05).Compared with laparotomy,laparoscopic group had less blood loss(P〈0.01),operative time,postoperative recovery feeding time,postoperative hospital stay,and time to drainage tube removal were significantly reduced(all P〈0.01),low incidence of wound fat liquefaction(P〈0.05).In the laparoscopic surgery group,compared with normal cholesterol,higher blood loss in patients with hyperlipidemia(P〈0.01),other indicators showed no significant difference.Conclusion: Hyperlipidemia can cause increased bleeding after rectal cancer surgery,and postoperative recovery was slow,the high incidence of wound fat liquefaction,Laparoscopic surgery can accelerate postoperative recovery.
出处 《现代生物医学进展》 CAS 2012年第10期1886-1888,共3页 Progress in Modern Biomedicine
关键词 高脂血症 直肠癌 腹腔镜 Hyperlipidemia Cancer Laparoscopic
  • 相关文献

参考文献19

  • 1Jacobs E J, Rodriguez C, Brady KA, et al. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort [J]. J Natl Cancer Inst, 2006, 98(1):69-72.
  • 2Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Relmert HS, et al. Statins and the risk of eolorectal cancer[J]. N Engl J Med, 2005, 352:2184-2192.
  • 3Herbey II, Ivankova NV, Katkoori VR, et al. Colorectal cancerand hypercholestemlemia: Review of current research [J]. ExpOncol, 2005, 27(3): 166-178.
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5224
  • 5曹磊,江志伟.结肠直肠癌的临床研究进展[J].临床肿瘤学杂志,2005,10(2):214-216. 被引量:17
  • 6彭心昭,李健,叶汉深,周思朗.结直肠癌远处转移与血脂变化的关系研究[J].临床肿瘤学杂志,2008,13(1):64-66. 被引量:6
  • 7Morgan D, Forssmann U, Nakada M. Cancer and Inflammation [J]. British Journal of Cancer, 2005, 92(9): 792-793.
  • 8Pollak MN, Scherhammer ES, Hankinon SE. lnsulun-like growth factors and neoplasma[J]. Nat Rev Cancer, 2004,4(3): 156-162.
  • 9Firestone RA. Lipid lowering agents may fight cancer by denying it LDL[J]. Int J Cancer, 2006, 119(10): 2497-2499.
  • 10Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolicsyndrome and risk of incident colorectal cancer [J]. Cancer, 2006, 107(1): 28-36.

二级参考文献207

共引文献5253

同被引文献15

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部